BRIUMVI
BNopenfda #3a77cd8c-811b-407c-9140-d0c5c26435c2lang: en
- Manufacturer
- TG Therapeutics, Inc.
- Ingredients
- UBLITUXIMAB
- Synonyms
- UBLITUXIMAB
- Routes
- INTRAVENOUS
Extra source metadata
{
"ndc": [
"73150-150"
],
"rxcui": [
"2626353",
"2626359"
],
"pharm_class_epc": [
"CD20-directed Cytolytic Antibody [EPC]"
],
"pharm_class_moa": [
"CD20-directed Antibody Interactions [MoA]"
]
}Source last updated 2026-05-24T14:39:40.127Z